Yüklüyor......
Engineered Endothelial Progenitor Cells That Overexpress Prostacyclin Protect Vascular Cells
Prostacyclin (PGI2) is a potent vasodilator and important mediator of vascular homeostasis; however, its clinical use is limited because of its short (<2 minute) half-life. Thus, we hypothesize that the use of engineered endothelial progenitor cells (EPCs) that constitutively secrete high levels...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3292628/ https://ncbi.nlm.nih.gov/pubmed/21938725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcp.23035 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|